CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...